Physician

Juan Manuel Ortega Legaspi, MD, PHD

According to 2025 Medicare claims, Juan Legaspi, MD, PHD (NPI: 1689989964) practices advanced heart failure and transplant cardiology in the Camden, NJ market, with the plurality of this provider's patient population coming from Burlington, NJ. This provider's primary affiliated billing organization is UNIVERSITY OF PENN - MEDICAL GROUP (NPI: 1093725145; TIN: 232743545) and primary practice location at 08103-3101.

Legaspi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 904 traditional Medicare patients, billed 2,222 HCPCS/CPT codes, and received $91,205 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 2,357 prescription claims across 234 beneficiaries totaling $824,041 in drug costs, led by Entresto (Sacubitril/Valsartan). 2022 DME data shows 11 claims. Open Payments data shows 35 records totaling $44,565. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,811 to $91,205. Similarly, Part D prescription costs have moved sharply higher in recent years, from $15,830 to $824,041. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	12	13	$1,811
2018	146	401	$27,290
2019	434	1,504	$99,125
2020	386	1,182	$79,247
2021	333	1,069	$77,538
2022	390	1,191	$79,753
2023	784	1,699	$78,507
2024	904	2,222	$91,205

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	46	190	$15,830
2016	25	55	$4,228
2017	N/R	N/R	N/R
2018	22	54	$2,758
2019	96	406	$39,055
2020	129	865	$115,684
2021	134	1,129	$296,344
2022	166	1,536	$472,988
2023	210	1,864	$670,123
2024	234	2,357	$824,041

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	101	$27,862
2020	N/R	43	$21,990
2021	N/R	63	$7,593
2022	N/R	11	$425
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	42	113	$166
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	144	234	$109
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	59	190	$62
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	156	255	$13
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	814	1,077	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	242	14,134	$308,172
Jardiance	Empagliflozin	160	9,042	$163,362
Farxiga	Dapagliflozin Propanediol	111	6,080	$111,676
Eliquis	Apixaban	101	5,463	$103,651
Xarelto	Rivaroxaban	31	1,890	$34,131

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$226	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	26	$44,339	Impulse Dynamics (USA) Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Juan Manuel Ortega Legaspi, MD, PHD?

Tedicare shows public-source Medicare data for Juan Manuel Ortega Legaspi, MD, PHD (NPI 1689989964), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Juan Manuel Ortega Legaspi, MD, PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Juan Manuel Ortega Legaspi, MD, PHD?

Juan Manuel Ortega Legaspi, MD, PHD is linked to UNIVERSITY OF PENN - MEDICAL GROUP (billing NPI 1093725145) in the available physician profile data.

Does Juan Manuel Ortega Legaspi, MD, PHD have Open Payments data?

Juan Manuel Ortega Legaspi, MD, PHD has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.